MCBC Holdings, Inc. Announces Closing of Secondary Offering
Dec 21, 2016 21:15 pm UTC| Business
VONORE, Tenn., Dec. 21, 2016 -- MCBC Holdings, Inc. (NASDAQ:MCFT) (the “Company”) today announced the closing of an underwritten secondary offering (the “Offering”) of 1,500,000 shares of its common stock held by...
BeiGene Announces First Patient Dosing in China with Investigational PARP Inhibitor BGB-290
Dec 21, 2016 21:15 pm UTC| Business
BEIJING, Dec. 21, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced the dosing of the...
Crown Castle to Present at the Citi 2017 Internet, Media & Telecommunications Conference
Dec 21, 2016 21:15 pm UTC| Business
HOUSTON, Dec. 21, 2016 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that Dan Schlanger, Crown Castle’s Chief Financial Officer, is scheduled to present on Wednesday, January 4, 2017 at...
TiGenix: Takeda Exercises its Option to Develop and Commercialize Cx601 in both Japan and Canada
Dec 21, 2016 21:07 pm UTC| Business
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda Exercises its Option to Develop and Commercialize Cx601 in both Japan and Canada Leuven (BELGIUM): December 21, 2016, 22:01h CET - TiGenix NV (Euronext...
Micron Technology, Inc., Reports Results for the First Quarter of Fiscal 2017
Dec 21, 2016 21:05 pm UTC| Business
BOISE, Idaho, Dec. 21, 2016 -- Micron Technology, Inc., (NASDAQ:MU) today announced results of operations for its first quarter of fiscal 2017, which ended December 1, 2016. Revenues for the first quarter of fiscal 2017...
Dec 21, 2016 21:05 pm UTC| Business
NEW YORK, Dec. 21, 2016 -- KCAP Financial, Inc. (“KCAP”) (Nasdaq:KCAP) (NYSE:KAP) announced that Catamaran CLO 2016-1 Ltd., a $408.5 million Collateralized Loan Obligation (“CLO”) fund has closed. Trimaran Advisors,...
Dec 21, 2016 21:05 pm UTC| Business
CAMBRIDGE, Mass., Dec. 21, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that it...